RepliCel Life Sciences Inc (OTCQB:REPCF)

0.2842
Delayed Data
As of Apr 23
 +0.0072 / +2.60%
Today’s Change
0.26
Today|||52-Week Range
0.77
-8.32%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues4.0M0.000.000.00
 
 
Depreciation And Amortization5.9K6.9K5.5K4.4K
 
 
 
 
 
 
Operating ExpensesGross Income---6.9K-5.5K-4.4K
 
 
 
 
General Expenses3.5M4.7M3.9M3.2M
 
 
 
 
 
Research And Development1.4M1.8M1.8M841.6K
 
 
 
 
 
Total Operating Expenses3.5M4.7M3.9M3.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income518.3K-4.7M-3.9M-3.2M
 
 
 
 
 
Extraordinary Credit0.000.002.8K0.00
 
 
Extraordinary Charge-136.0K-7.0K0.000.00
 
 
 
Other Expenses-10.1K3.2K-12.1K12.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income372.2K-4.7M-3.9M-3.2M
 
 
 
 
 
Income Taxes-399.9K0.000.000.00
 
 
Net Income-27.7K-4.7M-3.9M-3.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.5M5.1M5.7M8.0M
 
 
 
 
 
Shares To Calculate EPS Diluted4.5M5.1M5.7M8.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.00-$0.91-$0.70-$0.41
 
 
 
 
EPS Diluted-$0.01-$0.91-$0.70-$0.41